INTRODUCTION

CONSIDERABLE
indirect evidence, associating serotonin with central nervous system function and the actions of important psychotropic drugs, led to suggestions192 of a relationship between serotonin metabolism and schizophrenia. Despite considerable effort, experimental support for this suggestion has been inconclusive. Among studies in this area are those on quantitative excretion, and variability of excretion, of serotonin's major metabolite, 5-hydroxyindoleacetic acid, by various diagnostic populations, and on the relationship between such excretion and clinical symptomatology. Thus, schizophrenics have been reported variously to excrete supernormal,a-5 subnormal,6 and normal"3 amounts of this metabolite, and to show excessive variability in excretion. More recently a direct relationship between urinary levels of 5-hydroxyindoleacetic acid and other tryptophan metabolites and clinical symptomatology has been reported.rs-1s
As part of a larger multidisciplinary study on the attributes of schizophrenia,? it was possible to examine some of these reports on a large population maintained under controlled conditions.ls~sO The present paper deals with a comparison of the quantitative excretion of 5-hydroxyindoleacetic acid by various diagnostic populations, and an analysis of the correlations between such excretion and pertinent biological and behavioral variables.
ARTHUR k-UWlLER
MATERIALS AND METHODS
Subjects. Schizophrenic and nonschizophrenic subjects 18-50 years of age were drawn from the male population of Ypsilanti State Hospital. Admission to the research ward was contingent upon unanimous concordance on primary diagnosis (obtained independently by three psychiatrists) and the absence of concurrent physical illnesses. All psychiatrists had access to the medical records.
Diagnostic subdivisions into paranoid schizophrenic, non paranoid schizophrenic, nonschizophrenic with chronic brain syndrome, and nonschizophrenic without chronic brain syndrome were established by the majority judgment of the three psychiatrists on the predominant psychiatric and medical state of the subjects. While unanimity was not required, it was achieved in the majority of cases. 123 subjects (63 schizophrenics and 60 nonschizophrenics) were admitted to the research ward in diagnostically mixed groups of five. Medication was terminated two months before testing, and subjects were maintained on an unvarying diet with daily vitamin supplementation throughout their stay on the research ward. A three-week period of dietary adjustment was allowed. Baseline biochemical determinations were made during the fourth week when diet was rigidly controlled and ward observation carried out. Specimens were discarded from subjects failing to consume their diet completely. The mean age of the schizophrenics in this study was 35.8 f 8.25" years, and they had been hospitalized for 544 f 77.4 months. Psychiatric and ward ratings were carried out using Lorr MSRPP2r and the Gorham Ward Rating Scale.22 Specimens. Urines were collected over 24-hour p,eriods and were refrigerated at 5°C between collections. Analytical determinations were carried out daily. Estimations of 5-hydroxyindoleacetic acid were not carried out on samples having a pH greater than 6.9. Methods. Urinary 5-hydroxyindoleacetic acid was estimated by the procedure of UDEN-FRIEND et aZ.,23 creatinine by a Jaffe reactions4 and sodium by flame photometry. In most instances individual figures for 5-hydroxyindoleacetic acid and sodium are the average of two samples taken two days apart, while figures for total volume and urinary creatinine are the means for five determinations. Reported values, therefore, are the means of such individual averages. Cross-and intra-correlations were computed from daily individual 24-hour values, rather than pooled mean values, and the variables in question.
RESULTS AND DISCUSSION
Comparisons of the 5-hydroxyindoleacetic acid excretion by various diagnostic populations (Table 1) substantiate those investigations?14 concluding that schizophrenics and nonschizophrenics do not differ in 5-hydroxyindoleacetic acid excretions. Non paranoid schizophrenics did differ significantly (P <0.05) from both paranoid schizophrenics and nonschizophrenics with chronic brain syndrome in the urinary concentration of 5-hydroxyindoleacetic acid but not in total daily excretion. However, of the 30 cross comparisons * Mean f standard deviation. between schizophrenics, nonschizophrenics, and their various sub-populations in this analysis, one and one-half differences of the 0.05 level would be expected by chance alone, and it is unlikely that the two statistical differences observed had clinical significance.
It is also of interest that the variance was nearly identical for schizophrenics and nonschizophrenics;
and ranges of individual values for 24-hour excretion was also comparable between these groups. The extreme values for schizophrenics ranged from 1.09 mg/24 h (a non paranoid schizophrenic) to 12.79 mg/24 h (a paranoid schizophrenic) while the extremes among nonschizophrenics were 1 *l 1 mg/24 h to 11.69 mg/24 h (two nonschizophrenics without chronic brain syndrome). Thus, it would appear that schizophrenics do not show greater variability than nonschizophrenics on this measure when both are maintained under similar environmental conditions. It has been suggestedI' that 'exacerbations of schizophrenic activity in terms of aggravations of hallucinatory and delusional experiences as well as agressiveness and hostility' are accompanied by increased urinary excretion of tryptamine, indole-3-acetic acid, and 5-hydroxyindoleacetic acid. Correlations between 5-hydroxyindoleacetic acid excretion and various pertinent behavioral and biological variables were analyzed, therefore, to assess the validity of the postulated relationship for this compound.
The correlations between metabolite excretion and LORR~~ and GORHAM~~ rating factors, presented in Table 2 , not only fail to support this suggested relationship, but even suggest the opposite trend, of decreasing psychopathology with increasing 5-hydroxyindoleacetic acid excretion. Excretion of 5-hydroxyindoleacetic acid correlated significantly with withdrawal on both the Gorham 5 and Lorr I in the direction of less withdrawal with higher excretion, and with the Mental Disorganization Factor, Gorham 3, in the direction of less mental disorganization with higher excretion. Correlations with other rating factors failed to reach statistical significance, but, with the exception of the Lorr A, all were in the direction of decreased schizophrenic psychopathology with increased 5-hydroxyindoleacetic acid excretion. The Lorr I and the Gorham 5 in this study correlated remarkably well for these types of measures (r = O-764, P = 0.001, N = 99) so that both factors seem to be estimating similar phenomena. Although single rating factors may not fully reflect global pathology, 15 of the 17 Lorr and Gorham scale items distinguished schizophrenics from nonschizophrenics in this study and 10 did so at P <O.OOl.
Because of the difficulty in specifying clinical state and environmental conditions precisely it is conceivable that the negative relationship between 5-hydroxyindoleacetic acid and psychopathology observed in this cross-sectional study and the positive relationship reported in longitudinal studies may reflect extraneous influences on 5-hydroxyindoleacetic acid excretion. For example, the nine schizophrenic subjects studies by BERLET et a1.l' ranged in age from 39-59 years (mean 53) and were hospitalized for from 6-28 years (mean 19). The schizophrenics in our study were younger (35.8 f 8.2 years of age) and had been hospitalized for a lesser period (4.53 f 6.45 years). However, in our study, hospitalization (but not age) correlated negatively with 5-hydroxyindoleacetic acid excretion (r = -0.38 1; P cO.Ol), so that neither experimental difference alone appears to account for the differences in the findings. As expected, hospitalization and, to a lesser extent, age correlated positively with increasing psychopathology (Table 3) . The most reasonable remaining explanation of these findings is that 5-hydroxyindoleacetic acid reflects physical changes resulting from or accompanying psychopathology. Thus, and in agreement with the findings of BERLET et al. 26 , 24 h creatinine excretion correlated with 5-hydroxyindoleacetic acid excretion (r = +0*588; N = 61; P <O.OOl), as did 24 h urine volume (r = +0*399; P <O=OOl), 24 h urinary sodium (r = +0*506; P <O.OOl), and 24 h urinary potassium excretion (r = $0.404; P t0.001). Further, these latter variables also generally correlated with psychiatric items in the direction of decreasing values with increasing psychopathology (Table 3) , the opposite direction from that reported by BERLET et al.26 As anticipated, creatinine excretion, in this study, correlated positively for both schizophrenics and nonschizophrenics with such anthropometric measures as body weight, calf girth and lean body weight. Hospitalization, however, correlated negatively with the creatinine excretion of schizophrenics and positively with excretion by nonschizophrenics. A possible interpretation is that this reflects a gradual physical deterioration among schizophrenics during chronic hospitalization, in contrast to a physical restoration among nonschizophrenics, particularly sociopaths, during their shorter hospitalization. Chronic schizophrenic psychopathology, then, would be accompanied by a continued loss of muscle mass, reflected in decreased creatinine excretion, and decreased 5-hydroxyindoleacetic acid excretion. Transitory exacerbations of psychopathology superimposed on this basic pattern could temporarily hasten this degenerative process, increasing creatinine excretion during rapid loss of muscle mass, as suggested by BERLET et al., and concommitantly heighten excretion of Shydroxyindoleacetic acid. This interpretation, while reconciling these apparently discrepant findings, also suggests that 5-hydroxyindoleacetic acid excretion is more closely related to physical state than to psychopathology: however, a direct relationship between psychopathology and indole excretion is not excluded particularly since 5-hydroxyindoleacetic acid is considered a less sensitive indication of behavioral change than is tryptamine or indole3-acetic acid.
SUMMARY
Schizophrenics and nonschizophrenics do not differ in urinary excretion of 5-bydroxyindoleacetic acid on either a concentration or 24 h basis, nor do they differ in variability of excretion. Although a pattern was observed of decreasing psychopathology with increasing 5-hydroxyindoleacetic acid excretion, this pattern may be related to alterations in physical state accompanying psychopathology rather than to psychopathology per se.
